CAMPINA and PRAHOVA, Romania, July 20 BeikeBiotechnology Co. Ltd. (http://www.beikebiotech.com/index.php ), one of theworld's leading biotechnology companies focusing on adult stem cell therapies,opened Romania's first rehabilitation center to use traditional Chinese-stylerehabilitation techniques in Campina today.
The new Romanian center is Beike's first stand-alone rehabilitationfacility in the world. Physical rehabilitation is a key component of Beike'sstem cell therapy protocols which are utilized by leading hospitals throughoutChina. In conjunction with each one-month stem cell treatment cycle, mostpatients undergo extensive physical therapy and rehabilitation in an effort toenhance the effects of the stem cells. Chinese patients are able to continuewith the rehabilitation after the treatment is completed, but often overseaspatients can not find affordable therapy when they return home.
The new 240 square-meter center provides traditional Chinese acupuncture,massage, physical therapy, physiotherapy, electrotherapy and medicalexercise-based techniques to help patients with neurological and autoimmunediseases such as ataxia, multiple sclerosis, cardiovascular disease, spinalcord injuries and autoimmune disorders, among others.
In addition an important focus for the center is long-term data collection.The center will conduct cooperative studies with local physicians andscientists to determine the efficacy of stem cell treatments withrehabilitation compared to rehabilitation alone.
"We are extremely proud that Beike Biotechnology, the preeminent innovatorin stem cell therapies, has chosen our city as home to their firstrehabilitation center." noted Beike-Centru De Recuperare Medicala CenterDirector Gabi Razvan Iordache. A native of Campina, Razvan manages the centerwith the assistance of Camelia and Cristi Iordache.
Iordache Razvan was first introduced to Beike Biotech when he suffered aspinal cord injury in 1995 from a diving accident. After 11 years of therapyin Romania, Razvan traveled to a leading hospital in China that used Beikestem cells for his first treatment, in 2006. Each of the four times Razvanreturned from China, local media focused on his compelling story and theremarkable changes in his abilities that coincided with his journeys. As aresult, over the last four years more than 128 people have traveled to Chinafrom Romania to receive Beike's stem cell treatments at China's leadinghospitals.
Driven by the need to help others, Razvan decided to bring ChineseMedicine treatment protocols to Romania. He said, "During my treatment, Irealized not only were the stem cells beneficial to my condition, but therehab therapy I received during my time in China greatly enhanced my progress.I wanted to bring this advanced rehabilitation to Romania so my fellowcountrymen don't have to leave their country to feel better."
Unique in Romania, the new clinic is the only rehabilitation center in thecountry to offer care integrating traditional Chinese-style medicine withRomanian and Western modalities. The new center is a welcome addition to thecity of Campina, according to the city's mayor, Horia Tiseanu. Mr. Tiseanusaid, "This medical center is very important for our city. Our citizens nowhave access to more progressive health care. And, people from all over Romaniacan travel to Campina to benefit from these modern and efficient treatments."
About Beike Biotechnology Company Limited
Beike Biotechnology (http://www.beikebiotech.com ) is China's leadingbiotechnology company focusing on adult stem cell therapies. Beike'sscientists have been focused on the development and commercialization of adultstem cell therapies since 1999. The company currently produces a full line ofstem cell products from umbilical cord, cord blood, and bone marrow stem cells.Beike's stem cell therapies are administered by physicians at many leadinghospitals throughout China.
Beike's unique processing technologies prepare the cells for use intreating a variety of serious medical conditions including ataxia, braininjury, cerebral palsy, diabetic foot disease, lower limb ischemia, multiplesclerosis, muscular dystrophy, spinal cord injury and optic nerve pathologies.For more information, please contact: Shenzhen Beike Biotechnology Company, Ltd. T. Gutmann Shenzhen Hi-Tech Industrial Park Tel: +86-755-8630-9200 Email: firstname.lastname@example.org Web: http://www.beikebiotech.com
SOURCE Beike Biotechnology Company Limited